These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30905436)

  • 1. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
    Machida H; Matsuo K; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kanauchi M; Nagase S; Enomoto T; Mikami M
    Gynecol Oncol; 2019 Jun; 153(3):589-596. PubMed ID: 30905436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
    Matsuo K; Machida H; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Mikami M
    Obstet Gynecol; 2019 Nov; 134(5):1017-1026. PubMed ID: 31599824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas.
    Matsuo K; Matsuzaki S; Maeda M; Rau AR; Yoshihara K; Tamura R; Shimada M; Machida H; Mikami M; Klar M; Roman LD; Wright JD; Sood AK; Gershenson DM
    JAMA Netw Open; 2023 Jun; 6(6):e2318602. PubMed ID: 37326992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
    Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
    Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
    Vogel TJ; Goodman MT; Li AJ; Jeon CY
    Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The elevated risk of ovarian clear cell carcinoma among Asian Pacific Islander women in the United States is not affected by birthplace.
    Korenaga TR; Ward KK; Saenz C; McHale MT; Plaxe S
    Gynecol Oncol; 2020 Apr; 157(1):62-66. PubMed ID: 32008796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database.
    Yang SP; Su HL; Chen XB; Hua L; Chen JX; Hu M; Lei J; Wu SG; Zhou J
    JMIR Public Health Surveill; 2021 Nov; 7(11):e25976. PubMed ID: 34787583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period.
    Zhou Q; Zhu C; Shen Z; Zhang T; Li M; Zhu J; Qin J; Xie Y; Zhang W; Chen R; Wang G; Qian L; Wu D; Nashan B; Zhou Y
    Eur J Surg Oncol; 2020 May; 46(5):855-861. PubMed ID: 32001042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.
    Kim SI; Lim MC; Lim J; Won YJ; Seo SS; Kang S; Park SY
    J Gynecol Oncol; 2016 Jan; 27(1):e5. PubMed ID: 26463436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register.
    Trabert B; Aarestrup J; Ulrich LG; Wentzensen N; Sørensen TIA; Baker JL
    Gynecol Oncol; 2018 Mar; 148(3):547-552. PubMed ID: 29331371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
    Wentzensen N; Poole EM; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Butler LM; Chamosa S; Clendenen TV; Dossus L; Fortner R; Gapstur SM; Gaudet MM; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Jones M; Kaaks R; Kirsh V; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sandler DP; Schairer C; Schouten LJ; Sjöholm LK; Sieri S; Swerdlow A; Tjonneland A; Travis R; Trichopoulou A; van den Brandt PA; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
    J Clin Oncol; 2016 Aug; 34(24):2888-98. PubMed ID: 27325851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving population-based statistics for rare epithelial ovarian cancers.
    Matsuo K; Machida H; Matsuzaki S; Grubbs BH; Klar M; Roman LD; Sood AK; Gershenson DM; Wright JD
    Gynecol Oncol; 2020 Apr; 157(1):3-11. PubMed ID: 31954534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis.
    Doll KM; Winn AN
    Am J Obstet Gynecol; 2019 Oct; 221(4):318.e1-318.e9. PubMed ID: 31125544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma.
    Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Mikami M; Enomoto T; Katabuchi H; Aoki D
    J Gynecol Oncol; 2020 Jul; 31(4):e45. PubMed ID: 32026659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016.
    Knisely AT; St Clair CM; Hou JY; Collado FK; Hershman DL; Wright JD; Melamed A
    JAMA Netw Open; 2020 Sep; 3(9):e2017517. PubMed ID: 32975569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer.
    Song BB; Anderson ZS; Masjedi AD; Lee MW; Mandelbaum RS; Klar M; Roman LD; Wright JD; Matsuo K
    Obstet Gynecol; 2024 Jul; 144(1):68-78. PubMed ID: 38781594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The survival benefit associated with complete macroscopic resection in epithelial ovarian cancer is histotype specific.
    Porter JM; McFarlane I; Bartos C; Churchman M; May J; Herrington CS; Connolly KC; Ryan NAJ; Hollis RL
    JNCI Cancer Spectr; 2024 Jul; 8(4):. PubMed ID: 38902938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.